Literature DB >> 28079268

Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.

Dalia M Abd El Motteleb1, Dalia I Abd El Aleem2.   

Abstract

Oxidative stress and inflammation play a key role in the initiation and progression of diabetic nephropathy (DN). The present study aimed to investigate the possible protective effect of hypericum perforatum (HP) against DN. Rats were allocated into six groups: control, received normal saline; diabetic untreated (DM), received single dose of streptozotocin (STZ) after injection of nicotinamide (NA); gliclazide, received STZ,NA + gliclazide (10 mg/kg); DM + HP50, DM + HP100, DM + HP200, received STZ,NA and HP 50, 100, 200 mg/kg, respectively. Gliclazide and HP were administered daily via gavage for 8 weeks. Serum glucose, insulin, kidney function and histopathological picture were assessed. Furthermore, oxidative/nitrosative stress, inflammatory cytokines, apoptotic and fibrotic markers were measured. Diabetic untreated group showed increase in serum glucose, urea, creatinine with albuminurea. Renal expression of protein for nuclear factor kappa-B (NF-кB), renal expression of inducible nitric oxide synthase (iNOS), cyclooxygenase II (COXII), collagen IV, fibronectin were elevated. Malondialdehyde (MDA), nitric oxide (NO), tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), intracellular adhesion molecule (ICAM-1), monocellular chemoattractant protein-1 (MCP-1), tumour growth factor- β (TGF-β), caspase-3 and cytochrome c contents were also increased consequently with decline of serum insulin, expression of peroxisome proliferator-activated receptor (PPARγ), renal reduced glutathione (GSH) content and superoxide dismutase (SOD) activity. Treatment with either gliclazide or HP mitigated the deleterious effects of STZ on the tested parameters. These findings indicate for the first time that HP may have a renoprotective effect against DN through reduction of oxidative/nitrosative stress, enhancement of antioxidant defense mechanisms, decline of inflammatory cytokines, antifibrotic, antiapoptotic and blood glucose lowering properties.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  zzm321990hypericum perforatumzzm321990; NF-кB; PPAR γ; TGF-β; diabetic nephropathy; gliclazide; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28079268     DOI: 10.1111/1440-1681.12729

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

1.  Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.

Authors:  Massimo Dal Monte; Maurizio Cammalleri; Valeria Pecci; Monica Carmosino; Giuseppe Procino; Alessandro Pini; Mario De Rosa; Vincenzo Pavone; Maria Svelto; Paola Bagnoli
Journal:  J Cell Mol Med       Date:  2018-11-13       Impact factor: 5.310

2.  Effects of Calendula Officinalis and Hypericum Perforatum on Antioxidant, Anti-Inflammatory, and Histopathology Indices of Induced Periodontitis in Male Rats.

Authors:  Nader Tanideh; Vajiheh Ghafari; Reyhaneh Ebrahimi; Raha Habibagahi; Omid Koohi-Hosseinabadi; Aida Iraji
Journal:  J Dent (Shiraz)       Date:  2020-12

Review 3.  The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2022-09-02

Review 4.  Mechanisms of Herbal Nephroprotection in diabetes mellitus.

Authors:  Dorin Dragoș; Maria Mirabela Manea; Delia Timofte; Dorin Ionescu
Journal:  J Diabetes Res       Date:  2020-06-30       Impact factor: 4.011

Review 5.  Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.

Authors:  Michela Novelli; Pellegrino Masiello; Pascale Beffy; Marta Menegazzi
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

Review 6.  Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy.

Authors:  Jaqueline S da Silva; Renata G J Gonçalves; Juliana F Vasques; Bruna S Rocha; Bianca Nascimento-Carlos; Tadeu L Montagnoli; Rosália Mendez-Otero; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

7.  Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway.

Authors:  Pingping Li; Syed Nasir Abbas Bukhari; Tahseen Khan; Renukaradhya Chitti; Davan B Bevoor; Anand R Hiremath; Nagaraja SreeHarsha; Yogendra Singh; Kumar Shiva Gubbiyappa
Journal:  Int J Nanomedicine       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.